COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

A Phase II Study of Split-Dose R-CHOP in Older Adults with Diffuse Large B-cell Lymphoma

Protocol No
WON-SHAH-UW18131-SPLIT-RCHOP
Principal Investigator
Nirav Shah
Phase
II
Summary
This study will look at how effective this approach is in treating this type of cancer, and about treatment side effects in older adults with DLBCL, because the standard treatment for DLBCL is often more difficult for older adults to tolerate due to increased side effects and interactions with other medications or medical conditions.
Description
Split-Dose R-CHOP for Older Adults with DLBCL
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL